Faculty ProfilesCara Pellegrini
401 Parnassus Ave.
San Francisco, CA 94143
Dr. Pellegrini is the Acting Chief of Cardiology and the Cardiology Fellowship Site Director at the SFVA. She is particularly interested in the management of atrial fibrillation, most especially among those with heart failure. Additional interests include POTS, and the utilization and impact of ambulatory ECG monitoring.
Dr. Pellegrini is very involved with medical education, with a particular focus on the teaching of ECG interpretation. While she enjoys small group interactions, she delights in delivering engaging lectures to large groups. She is a member of the 2017 UCSF CORO Leadership Collaborative.
Education and Training
|Location||Degree or Training||Specialty||Date|
|UCSF||CORO Leadership Collaborative||06/2017|
|UCSF||ATCR Certificate||Clinical Research||06/2007|
|Hosp of the Univ of Pennsylvania||Residency||Internal Medicine||06/2004|
|University of Pennsylvania||MD||Medicine||05/2001|
|Princeton University||BA||Ecology and Evolutionary Bio||05/1997|
POTS, ablation, ambulatory ECG monitoring, atrial fibrillation, leadership, medical educationAwards and Honors
Best Oral Presentation by a Jr. Scientist, Bay Area Clinical Research Symposium, 2008
Postdoctoral Research Fellowship Grant, AHA Western States, 2006-2007
Recent Articles (14)
Singh DK, Viswanathan MN, Tanel RE, Lee RJ, Lee BK, Marcus GM, Olgin JE, Han F, Vedantham V, Tseng ZH, Pellegrini C, Kawamura M, Gerstenfeld EP, Badhwar N, Scheinman M. His overdrive pacing during supraventricular tachycardia: a novel maneuver for distinguishing atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia. Heart Rhythm. 2014 Aug; 11(8):1327-35.
Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008. Am J Cardiol. 2014 Jun 15; 113(12):2052-6.
Shalaby AA, Brumberg GE, Pointer L, Bekelman DB, Rumsfeld JS, Yang Y, Pellegrini CN, Heidenreich PA, Keung E, Massie BM, Varosy PD. Depression and outcome among veterans with implantable cardioverter defibrillators with or without cardiac resynchronization therapy capability. Pacing Clin Electrophysiol. 2014 Aug; 37(8):994-1001.
Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol. 2011 Aug 30; 58(10):1007-13.
Pellegrini CN, Vittinghoff E, Lin F, Hulley SB, Marcus GM. Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial. Heart. 2009 May; 95(9):704-8.
Pellegrini CN, Lee K, Olgin JE, Turakhia MP, Tseng ZH, Lee R, Badhwar N, Lee B, Varosy PD. Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace. 2008 Nov; 10(11):1296-301.
Pellegrini CN, Yeh RW, Olgin J, Lee BK. Episodic ventricular pacing with intact atrioventricular nodal function in a DDDR device: what is the rhythm and how can it be prevented? Heart Rhythm. 2008 Jun; 5(6):897-8.